In a revolutionary treatment for early-onset scoliosis (EOS), a team of surgeons implanted adjustable growing rods in two children from California. The pioneering surgeries — the first ever in the United States — were performed on May 7th at Rady Children’s Hospital in San Diego. The Food and Drug Administration (FDA) granted Compassionate Use approval to use the MAGEC™ (MAGnetic Expansion Control) System, developed by Ellipse Technologies, Inc., for these two patients.
To view Multimedia News Release, go to http://www.multivu.com/mnr/61604-rady-children-s-hospital-san-diego-ellipse-magec-early-onset-scoliosis-eos
Female Texas Ranger Caitlin Strong races to a stop a second Civil War being orchestrated by a right wing militia group led by Malcolm Arno. Twenty years ago Caitlin’s father gunned down his to prevent a similar debacle and now history is about to repeat itself with thousands of lives at stake. Learn more about this book and its author here, http://www.jonlandbooks.com Suspense
The University of Texas Health Science Center at Houston (UTHealth) has begun enrollment for the first Phase I safety study approved by the Food and Drug Administration to investigate the use of a child’s own umbilical cord blood stem cells for traumatic brain injury in children. The study is being performed in conjunction with Children’s Memorial Hermann Hospital, UTHealth’s primary children’s teaching hospital.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/cordblood/48021/
With the Dec. 7 deadline for Medicare’s annual enrollment period fast approaching, Smart Insurance Company is working with Walgreens to offer in–store consultations with licensed SmartD Rx plan agents, available at select Walgreens to speak with Medicare beneficiaries who are either enrolling in a new Part D prescription drug plan or evaluating their current coverage options.
To view Multimedia News Release, go to http://www.multivu.com/mnr/59273-smart-insurance-company-walgreens-smartd-rx-open-enrollment-ends-dec-7
SIRO Clinpharm, a leading full service clinical research organization, unveiled its new brand identity on Friday. The new look affirms the recent transformation in the company’s business strategy.
“With the vast experience garnered over the past 16 years, SIRO was set to take a leap forward. With its customer centric leadership, we have built depth in various areas of competencies, leveraging our 4 pillars – people, processes, technologies and solutions,” said Dr. Gautam Daftary, founder and chairman, SIRO Clinpharm.
To view Multimedia News Release, go to http://www.multivu.com/mnr/58672-SIRO-Clinpharm-unveils-new-brand-identity
Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), announced today that its first doses of the Fluzone® (Influenza Vaccine) portfolio for the 2017-2018 influenza (“flu”) season have been released by the U.S. Food and Drug Administration (FDA). Sanofi Pasteur has begun distributing initial shipments, representing the first of nearly 70 million total doses of seasonal influenza vaccine manufactured by the company for this upcoming influenza season. Widespread shipment of Fluzone Quadrivalent, Fluzone High-Dose and Fluzone Intradermal Quadrivalent vaccine to health care provider offices, pharmacies and other immunizers will begin in early August to support fall immunization campaigns.
“As we enter the Swiftwater site’s 120th year, it reminds us of our innovation and growth as we came to understand the science of influenza and its impact on human health,” said David P. Greenberg, M.D., Associate Vice President and Regional Medical Head North America, Sanofi Pasteur. “Influenza can be especially severe for the most vulnerable populations, including the elderly, young children and those with compromised immune systems; however, it can also have a serious health impact on otherwise healthy individuals. Sanofi Pasteur is and always has been deeply committed to improving public health by continuously striving to develop new vaccines and on improving existing ones.”
To view the multimedia release go to:
https://www.multivu.com/players/English/8081151-sanofi-pasteur-influenza-vaccine-first-shipment-2017/
Whether from a supermarket, farm stand, or your own garden, fresh fruits and vegetables are highlights of summertime. The U.S. Food and Drug Administration reminds you that foodborne bacteria multiply faster in warm weather – and what’s more, safe handling of produce and fresh-squeezed juice is especially important because these foods are often consumed raw.
Keep foods safe this summer by practicing the Four Steps to Food Safety: clean hands and surfaces often; separate raw meats from other foods; cook to the right temperatures; and chill foods promptly. And with delicious, nutritious produce and fresh-squeezed juices, follow these additional tips to prevent food poisoning.
To view Multimedia News Release, go to https://www.multivu.com/mnr/50947-usfda-foodborne-bacteria-safe-handling-food-produce-fresh-juice
Mary Rose just wants to fit in and make friends…but that’s not that easy when you’re carrying around a deadly secret. Find out more at dearnobodydiary.com. YA, Non-Fiction
Click: http://rhettmay.com/ “A Little White Powder Under Your Nose” by Rhett May. A video about a crazy lady selling her body to finance here drug addiction!
Express Scripts clinical innovations saved its clients $45 billion in 2018 and delivered a 25-year record low drug trend of just 0.4 percent across employer-sponsored plans, according to data released today in its annual Drug Trend Report, an authoritative analysis of drug spending in the U.S.
Express Scripts’ solutions for driving lower drug prices and fostering the use of lower-net-cost treatments are making medication more accessible for beneficiaries. Unit drug costs decreased in 2018 for employer-sponsored and Medicare plans, while utilization of medications rose.
To view the multimedia release go to:
https://www.multivu.com/players/English/8478051-express-scripts-2018-drug-trend-report/
Nonfiction – This is a true account – a memoir – of a single mother losing everything, including her 2 children, Jayden and Annie, to a wretched alcohol and drug addiction; and ultimately losing herself. Yet through the storm, she finds the strength to overcome this addiction, as a result gaining more than ever before. “Freedom has never been sweeter.” Though her story starts out in despair, it ends on a positive note, providing hope to all those that read it. Learn more about this book here, http://alisamassey.com Inspirational Christian memoir about overcoming personal obstacles (drugs and alcohol).
Upsher-Smith Laboratories, Inc. today announced the nationwide launch of Provella™, a unique probiotic dietary supplement specifically designed for women to promote digestive, feminine, and immune health.* Provella™ helps restore and maintain balance of good bacteria to support digestive and vaginal health.* Taken once-daily by mouth, Provella™ tablets contain a proprietary blend of six bacteria strains that include: Lactobacillus acidophilus, Lactobacillus plantarum, Lactobacillus rhamnosus, Lactobacillus fermentum, Lactobacillus reuteri, and Bifidobacterium bifidum.
Provella™ is available without a prescription behind the pharmacy counter at retail pharmacies nationwide and online at www.drugstore.com. Consumers can also ask any local pharmacist to order Provella™ using List Number 0245-1060-30.
To view Multimedia News Release, go to http://www.multivu.com/mnr/56871-upsher-smith-provella-probiotic-supports-digestive-feminine-immune-health
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
